Clinical efficacy in bleeding and surgery in von Willebrand patients treated with Fanhdi^® a highly purified, doubly inactivated FVIII/VWF concentrate

Epidemiological investigation of the prevalence of von Willebrand's disease

1987 • 956 citations

A Revised Classification of von Willebrand Disease

1994 • 595 citations

Impact, Diagnosis and Treatment of von Willebrand Disease

2000 • 491 citations

Treatment of von Willebrand's Disease

2004 • 483 citations

Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study

2002 • 187 citations

von Willebrand Factor: Structure and Function

1993 • 178 citations

Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation

2001 • 174 citations

How I treat patients with von Willebrand disease

2001 • 171 citations

Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial

1992 • 115 citations

Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial

1992 • 99 citations

Pharmacokinetics, efficacy and safety of Humate‐P^® in von Willebrand disease

1998 • 97 citations

Use of a High‐Purity Factor VIII Concentrate (Hemate P) in von Willebrand's Disease¹

1989 • 69 citations

Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type III

1992 • 69 citations

Clinical efficacy of highly purified, doubly virus‐inactivated factor VIII/von Willebrand factor concentrate (Fanhdi^®) in the treatment of von Willebrand disease: a retrospective clinical study

2002 • 58 citations

Diagnosis of von Willebrand disease

1998 • 51 citations

Management of inherited von Willebrand disease

2001 • 40 citations

Haemate P<sup>®</sup> in Children with von Willebrand’s Disease

1994 • 38 citations

Platelet aggregation and pseudothrombocytopenia induced by 1‐desamino‐8‐D‐arginine vasopressin (DDAVP) in type IIB von Willebrand's disease patient

1990 • 27 citations

von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.

1999 • 11 citations